RW effectiveness of tralokinumab in adults with atopic dermatitis on the genitals: Interim data on improvements in physician-assessed disease severity and PRO in up to 3 months of treatment (TRACE)
Por:
Serra-Baldrich, E, Armstrong, AW, Festini, T, Ivens, U, Nielsen, IV, Wiseman, M, Krüger-Szabo, A
Publicada:
1 abr 2025
Resumen:
Filiaciones:
Serra-Baldrich, E:
Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Dermatol, Barcelona, Spain
Armstrong, AW:
Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA
Festini, T:
LEO Pharm, Ballerup, Denmark
Ivens, U:
LEO Pharm, Ballerup, Denmark
Nielsen, IV:
LEO Pharm, Ballerup, Denmark
Wiseman, M:
SKiNWISE Dermatol, Winnipeg, MB, Canada
Krüger-Szabo, A:
LEO Pharm GmbH, Neu Isenburg, Germany
|